Potential influence of FDA-sponsored studies of antiepilepsy drugs on generic and brand-name formulation prescribing

Gregory L. Krauss

doi:10.1001/jamaneurol.2017.0492

Potential influence of FDA-sponsored studies of antiepilepsy drugs on generic and brand-name formulation prescribing

Gregory L. Krauss

School of Medicine

Research output: Contribution to journal › Editorial › peer-review

3 Scopus citations

Original language	English (US)
Pages (from-to)	900-901
Number of pages	2
Journal	JAMA Neurology
Volume	74
Issue number	8
DOIs	https://doi.org/10.1001/jamaneurol.2017.0492
State	Published - Aug 2017

ASJC Scopus subject areas

Clinical Neurology

Access to Document

10.1001/jamaneurol.2017.0492

Cite this

@article{e8e3cceae98d464788e8fc367d8db262,

title = "Potential influence of FDA-sponsored studies of antiepilepsy drugs on generic and brand-name formulation prescribing",

author = "Krauss, {Gregory L.}",

year = "2017",

month = aug,

doi = "10.1001/jamaneurol.2017.0492",

language = "English (US)",

volume = "74",

pages = "900--901",

journal = "JAMA Neurology",

issn = "2168-6149",

publisher = "American Medical Association",

number = "8",

}

TY - JOUR

T1 - Potential influence of FDA-sponsored studies of antiepilepsy drugs on generic and brand-name formulation prescribing

AU - Krauss, Gregory L.

PY - 2017/8

Y1 - 2017/8

UR - http://www.scopus.com/inward/record.url?scp=85027456995&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85027456995&partnerID=8YFLogxK

U2 - 10.1001/jamaneurol.2017.0492

DO - 10.1001/jamaneurol.2017.0492

M3 - Editorial

C2 - 28655026

AN - SCOPUS:85027456995

SN - 2168-6149

VL - 74

SP - 900

EP - 901

JO - JAMA Neurology

JF - JAMA Neurology

IS - 8

ER -

Potential influence of FDA-sponsored studies of antiepilepsy drugs on generic and brand-name formulation prescribing

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this